Saxenda weight-loss results
Saxenda produced 8% mean body-weight reduction in the SCALE pivotal trial at 56 weeks — substantially more than placebo and competitive with other approved weight-loss medications. This page details the clinical evidence, eligibility criteria, and what individual results look like in practice.
How effective is Saxenda?
Mean body-weight change at 56 weeks in the SCALE trial. Source: FDA prescribing information.
Saxenda−8%
8%
Placebo−2.6%
GLP-1 class ceiling (tirzepatide / SURMOUNT-1)−22.5%
22.5%
Vs placebo
+5.4 pts
Moderate signal